全文获取类型
收费全文 | 214篇 |
免费 | 7篇 |
国内免费 | 1篇 |
专业分类
儿科学 | 2篇 |
妇产科学 | 3篇 |
基础医学 | 41篇 |
口腔科学 | 3篇 |
临床医学 | 38篇 |
内科学 | 40篇 |
皮肤病学 | 8篇 |
神经病学 | 5篇 |
特种医学 | 3篇 |
外科学 | 23篇 |
预防医学 | 21篇 |
眼科学 | 4篇 |
药学 | 12篇 |
肿瘤学 | 19篇 |
出版年
2021年 | 21篇 |
2020年 | 9篇 |
2019年 | 15篇 |
2018年 | 6篇 |
2017年 | 4篇 |
2016年 | 2篇 |
2015年 | 8篇 |
2014年 | 8篇 |
2013年 | 5篇 |
2012年 | 11篇 |
2011年 | 12篇 |
2010年 | 4篇 |
2008年 | 6篇 |
2007年 | 6篇 |
2006年 | 7篇 |
2005年 | 4篇 |
2004年 | 6篇 |
2003年 | 4篇 |
2002年 | 4篇 |
2001年 | 3篇 |
2000年 | 2篇 |
1999年 | 2篇 |
1992年 | 6篇 |
1991年 | 3篇 |
1990年 | 2篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1986年 | 3篇 |
1985年 | 5篇 |
1984年 | 3篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1980年 | 1篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1977年 | 2篇 |
1976年 | 1篇 |
1975年 | 2篇 |
1974年 | 3篇 |
1973年 | 3篇 |
1972年 | 3篇 |
1971年 | 2篇 |
1970年 | 3篇 |
1969年 | 2篇 |
1968年 | 3篇 |
1967年 | 3篇 |
1966年 | 6篇 |
1965年 | 2篇 |
1964年 | 1篇 |
排序方式: 共有222条查询结果,搜索用时 93 毫秒
1.
Robert M. Levy Roman Saikovsky Evgeniya Shmidt Alexander Khokhlov Bruce P. Burnett 《Nutrition Research》2009
Flavocoxid (Limbrel), a proprietary mixture of flavonoid molecules (baicalin and catechin), was tested against a traditional nonsteroidal anti-inflammatory drug, naproxen, for the management of the signs and symptoms of moderate osteoarthritis (OA) in humans. Discomfort and global disease activity were used as the primary end points, and safety assessments were also taken for both treatments as a secondary endpoint. In this double-blind study, 103 subjects were randomly assigned to receive either flavocoxid [500 mg twice daily (BID)] or naproxen (500 mg BID) in a 1-month onset of action trial. Outcome measures included the short Western Ontario and McMaster University Osteoarthritis Index, subject Visual Analogue Scale for discomfort and global response, and investigator Visual Analogue Scale for global response and fecal occult blood. Both flavocoxid and naproxen showed significant reduction in the signs and symptoms of knee OA (P ≤ .001). There were no statistically detectable differences between the flavocoxid and naproxen groups with respect to any of the outcome variables. Similarly, there were no statistically detectable differences between the groups with respect to any adverse event, although there was a trend toward a higher incidence of edema and nonspecific musculoskeletal discomfort in the naproxen group. In this short-term pilot study, flavocoxid was as effective as naproxen in controlling the signs and symptoms of OA of the knee and would present a safe and effective option for those individuals on traditional nonsteroidal anti-inflammatory drugs or cyclooxygenase-2 inhibitors. A low incidence of adverse events was reported for both groups. 相似文献
2.
3.
4.
Matthew Bohm Ronghui Xu Yiran Zhang Sashidhar Varma Monika Fischer Gursimran Kochhar Brigid Boland Siddharth Singh Robert Hirten Ryan Ungaro Eugenia Shmidt Karen Lasch Vipul Jairaith David Hudesman Shannon Chang Dana Lukin Arun Swaminath Bruce E. Sands Jean-Frederic Colombel Sunanda Kane Edward V. Loftus Jr Bo Shen Corey A. Siegel William J. Sandborn Parambir S. Dulai the VICTORY Collaboration 《Alimentary pharmacology & therapeutics》2020,52(4):669-681
5.
6.
The dopamine transporter (DAT) plays an important homeostatic role in the control of both the extracellular and intraneuronal concentrations of dopamine, thereby providing effective control over activity of dopaminergic transmission. Since brain dopamine is known to be involved in numerous neuropsychiatric disorders, investigations using mice with genetically altered DAT function and thus intensity of dopamine-mediated signaling have provided numerous insights into the pathology of these disorders and novel pathological mechanisms that could be targeted to provide new therapeutic approaches for these disorders. In this brief overview, we discuss recent investigations involving animals with genetically altered DAT function, particularly focusing on translational studies providing new insights into pathology and pharmacology of dopamine-related disorders. Perspective applications of these and newly developed models of DAT dysfunction are also discussed. 相似文献
7.
8.
Gennady Sukhikh Ulyana Petrova Andrey Prikhodko Natalia Starodubtseva Konstantin Chingin Huanwen Chen Anna Bugrova Alexey Kononikhin Olga Bourmenskaya Alexander Brzhozovskiy Evgeniya Polushkina Galina Kulikova Alexander Shchegolev Dmitry Trofimov Vladimir Frankevich Evgeny Nikolaev Roman G. Shmakov 《Viruses》2021,13(3)
The effects of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in women on the gestation course and the health of the fetus, particularly in the first and second trimesters, remain very poorly explored. This report describes a case in which the normal development of pregnancy was complicated immediately after the patient had experienced Coronavirus disease 2019 (COVID-19) at the 21st week of gestation. Specific conditions included critical blood flow in the fetal umbilical artery, fetal growth restriction (1st percentile), right ventricular hypertrophy, hydropericardium, echo-characteristics of hypoxic-ischemic brain injury (leukomalacia in periventricular area) and intraventricular hemorrhage at the 25th week of gestation. Premature male neonate delivered at the 26th week of gestation died after 1 day 18 h due to asystole. The results of independent polymerase chain reaction (PCR), mass spectrometry and immunohistochemistry analyses of placenta tissue, umbilical cord blood and child blood jointly indicated vertical transmission of SARS–CoV-2 from mother to the fetus, which we conclude to be the major cause for the development of maternal vascular malperfusion in the studied case. 相似文献
9.
10.
Evgeniya Bogatyrenko Pascal Pompey Uwe D. Hanebeck 《International journal of computer assisted radiology and surgery》2011,6(3):387-399